Terms: = Skin cancer AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE
34 results:
1. Silencing of dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression.
Yeh YW; Hsu TW; Su YH; Wang CH; Liao PH; Chiu CF; Tseng PC; Chen TM; Lee WR; Tzeng YS
Aging (Albany NY); 2023 Nov; 15(22):12873-12889. PubMed ID: 37976135
[TBL] [Abstract] [Full Text] [Related]
2. A primary dicer1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL.
Yang K; Wang J; Kanwar N; Villani A; Ajani O; Fleming A; Patil V; Mamatjan Y; Wei Q; Malkin D; Shlien A; Zadeh G; Provias J
Brain Tumor Pathol; 2022 Oct; 39(4):225-231. PubMed ID: 35668302
[TBL] [Abstract] [Full Text] [Related]
3. Mutational landscape in squamous cell carcinoma of the nail unit.
Dika E; de Biase D; Lambertini M; Alessandrini AM; Acquaviva G; De Leo A; Tallini G; Ricci C; Starace M; Misciali C; Piraccini BM
Exp Dermatol; 2022 Jun; 31(6):854-861. PubMed ID: 34951714
[TBL] [Abstract] [Full Text] [Related]
4. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients.
Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH
Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149
[TBL] [Abstract] [Full Text] [Related]
5. dicer1-Mutated Botryoid Fibroepithelial Polyp of the Parotid Duct: Report of the First Case.
Erber R; Preidl R; Stoehr R; Haller F; Hartmann A; Kesting M; Agaimy A
Head Neck Pathol; 2022 Jun; 16(2):573-580. PubMed ID: 34282560
[TBL] [Abstract] [Full Text] [Related]
6. Primary Biphasic Hepatic Sarcoma in dicer1 Syndrome.
See SC; Wadhwani NR; Yap KL; Arva NC
Pediatr Dev Pathol; 2021; 24(5):484-488. PubMed ID: 33872107
[TBL] [Abstract] [Full Text] [Related]
7. Non-medullary Thyroid cancer Susceptibility Genes: Evidence and Disease Spectrum.
Zhou J; Singh P; Yin K; Wang J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Lubitz CC; Hughes KS
Ann Surg Oncol; 2021 Oct; 28(11):6590-6600. PubMed ID: 33660127
[TBL] [Abstract] [Full Text] [Related]
8. Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor dicer.
Lim SK; Tabatabaeian H; Lu SY; Kang SA; Sundaram GM; Sampath P; Chan SW; Hong WJ; Lim YP
Cell Death Dis; 2020 Aug; 11(8):669. PubMed ID: 32820148
[TBL] [Abstract] [Full Text] [Related]
9. Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent dicer1 alterations-is the term "thyroblastoma" more appropriate?
Agaimy A; Witkowski L; Stoehr R; Cuenca JCC; González-Muller CA; Brütting A; Bährle M; Mantsopoulos K; Amin RMS; Hartmann A; Metzler M; Amr SS; Foulkes WD; Sobrinho-Simões M; Eloy C
Virchows Arch; 2020 Dec; 477(6):787-798. PubMed ID: 32507920
[TBL] [Abstract] [Full Text] [Related]
10. ADAR1p150 regulates the biosynthesis and function of miRNA-149* in human melanoma.
Yujie Ding MM; Shi X; Ji J; Su Y
Biochem Biophys Res Commun; 2020 Mar; 523(4):900-907. PubMed ID: 31959472
[TBL] [Abstract] [Full Text] [Related]
11. dicer Sequencing, Whole Genome Methylation Profiling, mRNA and smallRNA Sequencing Analysis in Basal Cell Carcinoma.
Sand M; Bromba A; Sand D; Gambichler T; Hessam S; Becker JC; Stockfleth E; Meyer T; Bechara FG
Cell Physiol Biochem; 2019; 53(5):760-773. PubMed ID: 31647206
[TBL] [Abstract] [Full Text] [Related]
12. CD95/Fas ligand mRNA is toxic to cells.
Putzbach W; Haluck-Kangas A; Gao QQ; Sarshad AA; Bartom ET; Stults A; Qadir AS; Hafner M; Peter ME
Elife; 2018 Oct; 7():. PubMed ID: 30324908
[TBL] [Abstract] [Full Text] [Related]
13. Synthetic siRNA targeting human papillomavirus 16 E6: a perspective on in vitro nanotherapeutic approaches.
Togtema M; Jackson R; Grochowski J; Villa PL; Mellerup M; Chattopadhyaya J; Zehbe I
Nanomedicine (Lond); 2018 Feb; 13(4):455-474. PubMed ID: 29382252
[TBL] [Abstract] [Full Text] [Related]
14. Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism.
Putzbach W; Gao QQ; Patel M; van Dongen S; Haluck-Kangas A; Sarshad AA; Bartom ET; Kim KA; Scholtens DM; Hafner M; Zhao JC; Murmann AE; Peter ME
Elife; 2017 Oct; 6():. PubMed ID: 29063830
[TBL] [Abstract] [Full Text] [Related]
15.
Schultz KAP; Rednam SP; Kamihara J; Doros L; Achatz MI; Wasserman JD; Diller LR; Brugières L; Druker H; Schneider KA; McGee RB; Foulkes WD
Clin Cancer Res; 2017 Jun; 23(12):e76-e82. PubMed ID: 28620008
[No Abstract] [Full Text] [Related]
16. Overexpression of Drosha, DiGeorge syndrome critical region gene 8 (DGCR8), and dicer mRNAs in the pathogenesis of psoriasis.
Rostami Mogaddam M; Safavi Ardabili N; Shafaeei Y; Maleki N; Jafari N; Jafari A
J Cosmet Dermatol; 2017 Dec; 16(4):e48-e53. PubMed ID: 28342199
[TBL] [Abstract] [Full Text] [Related]
17. Mutation Scanning of D1705 and D1709 in the RNAse IIIb Domain of MicroRNA Processing Enzyme dicer in Cutaneous Melanoma.
Sand M; Bechara FG; Skrygan M; Sand D; Gambichler T; Bromba M; Stockfleth E; Hessam S
Pathol Oncol Res; 2016 Jul; 22(3):639-41. PubMed ID: 26683837
[TBL] [Abstract] [Full Text] [Related]
18. Next-generation sequencing of the basal cell carcinoma miRNome and a description of novel microRNA candidates under neoadjuvant vismodegib therapy: an integrative molecular and surgical case study.
Sand M; Bechara FG; Gambichler T; Sand D; Friedländer MR; Bromba M; Schnabel R; Hessam S
Ann Oncol; 2016 Feb; 27(2):332-8. PubMed ID: 26578727
[TBL] [Abstract] [Full Text] [Related]
19. Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.
Zhang G; Cheng Y; Chen G; Tang Y; Ardekani G; Rotte A; Martinka M; McElwee K; Xu X; Wang Q; Zhou Y
Oncotarget; 2015 Sep; 6(26):23026-35. PubMed ID: 26246476
[TBL] [Abstract] [Full Text] [Related]
20. Stage-specific prognostic biomarkers in melanoma.
Cheng Y; Lu J; Chen G; Ardekani GS; Rotte A; Martinka M; Xu X; McElwee KJ; Zhang G; Zhou Y
Oncotarget; 2015 Feb; 6(6):4180-9. PubMed ID: 25784655
[TBL] [Abstract] [Full Text] [Related]
[Next]
